Where it started
Pluto launched out of Harvard's Wyss Institute for Biologically Inspired Engineering — the lab that built the organ-on-a-chip field. Its founding director sits on our advisory board.
About
Six years of building for translational science.
And it doesn't need another dashboard. It needs persistent context — data, decisions, and reasoning that carry forward instead of resetting with every new analysis. Our multi-omics analysis architecture, modular since we started in 2020, is the substrate that makes agentic translational reasoning possible.
Our foundation
We have been shipping multi-omics analysis since 2021. The modular, callable architecture the harness runs on was built long before it was fashionable to need one.
Inside enterprise pharma
Live deployments running on real discovery programs inside customer infrastructure.
The record
Every milestone, dated.
Funding, product, partnerships and recognition — the whole arc from a Wyss spinout to a framework running inside enterprise pharma.
- 2026
The Translational Alignment Framework, in production
Forty-two criteria across four dimensions, running on live discovery programs inside enterprise pharma infrastructure.
- 2025
$3.6M to expand the AI-powered platform
Led by Kickstart with continued support from Silverton Partners, to take multi-omics analysis into pharma at scale.
- 2024
Wyss Brain Targeting Program
Pluto used by the Wyss Institute's Brain Targeting Program in the discovery of new transport targets for brain drug delivery.
-
Products That Count award
Selected as a winner of the 2024 Q2 Product Awards hosted by Products That Count.
-
BioTools Innovator 2024 cohort
Named among the top 20 life sciences companies in the BioTools Innovator programme.
- 2023
G2 High Performer, Pharma & Biotech
Awarded High Performer in the G2 Grid Report for Pharma & Biotech, Fall 2023.
-
Benchling integration launches
The ELN and the analysis layer connected — evidence lands where the work already happens.
-
Named a Top Vertical SaaS company to watch
Recognised by Headline VC and Bain Capital Ventures in their 2023 list.
-
$3.7M seed led by Silverton Partners
Funding to scale the platform across pharma and academic research teams.
- 2022
Featured at Bio-IT World Best of Show
Pluto featured in Bio-IT World's Best of Show highlights of new products in bio-IT.
- 2021
$1M seed round closes
Early capital to build an industry-first collaborative life sciences platform.
-
The collaborative platform ships
First cloud-based platform release — storage, analysis and visualization for biological data in one place.
-
Launches out of Harvard's Wyss Institute
Pluto Biosciences launches from the Wyss Institute for Biologically Inspired Engineering to speed scientific discovery.
- 2020
Pluto is founded in Denver, Colorado
Started by a computational biologist who had spent years watching good science get stranded in spreadsheets and slide decks.
Leadership
Led by people deep in the science.
Rani Powers, Ph.D.
Founder & CEO
A computational biologist who spent years watching good science get stranded in spreadsheets and slide decks, and founded Pluto in 2020 to change that.
Guiding the evolution
Advisory board
Scientists and operators deep in translational research and life sciences technology.
Investors
Backed by
Come see what six years bought.
A working framework, running on real programs, inside real infrastructure.
Book a demo